Danaher Corporation (DHR)
Price:
209.52 USD
( + 0.33 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Agilent Technologies, Inc.
VALUE SCORE:
7
2nd position
Qiagen N.V.
VALUE SCORE:
9
The best
Quest Diagnostics Incorporated
VALUE SCORE:
9
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
NEWS
Baron Durable Advantage Fund Q4 2025 Performance Review
seekingalpha.com
2026-02-26 02:00:00During the fourth quarter, we initiated a new position in the leading energy-focused specialty contracting company, Quanta Services. Within the existing portfolio, our biggest addition during the quarter was to MSCI, a leading provider of indexes and investment decision support tools. We also added to our position in Danaher Corporation.
Danaher Announces Quarterly Dividend
prnewswire.com
2026-02-24 16:30:00WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026 to holders of record on March 27, 2026. ABOUT DANAHER Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health.
Danaher to Present at TD Cowen Health Care Conference
prnewswire.com
2026-02-24 16:05:00WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 3, 2025 at 1:50 p.m.
Clearstead Advisors LLC Grows Stock Position in Danaher Corporation $DHR
defenseworld.net
2026-02-23 06:12:42Clearstead Advisors LLC grew its position in shares of Danaher Corporation (NYSE: DHR) by 4.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 93,939 shares of the conglomerate's stock after buying an additional 3,589 shares during the period. Clearstead Advisors LLC's
Danaher Corporation $DHR Position Boosted by Avalon Trust Co
defenseworld.net
2026-02-23 04:05:04Avalon Trust Co lifted its holdings in Danaher Corporation (NYSE: DHR) by 5.1% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 78,807 shares of the conglomerate's stock after purchasing an additional 3,847 shares during the period. Danaher comprises 1.0% of
Beverly Hills Private Wealth LLC Acquires Shares of 3,382 Danaher Corporation $DHR
defenseworld.net
2026-02-21 04:18:47Beverly Hills Private Wealth LLC bought a new position in shares of Danaher Corporation (NYSE: DHR) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,382 shares of the conglomerate's stock, valued at approximately $671,000. Other large investors have also
Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI
businesswire.com
2026-02-18 20:30:00NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Masimo Corporation (NasdaqGS: MASI) to Danaher Corporation (NYSE: DHR). Under the terms of the proposed transaction, shareholders of Masimo will receive $180.00 in cash for each share of Masimo that they own. KSF is seeking to determine whether this consideration and the process that led to it are a.
Danaher's $9.9B Masimo Deal Marks One of 2026's Largest Medtech Buyouts
247wallst.com
2026-02-18 08:50:55Danaher (NYSE: DHR) is acquiring Masimo (NASDAQ: MASI) for $9.9 billion in an all-cash deal that values the medical technology company at $180 per share.
Daniel Loeb's Strategic Moves: Flutter Entertainment PLC Exits with -3.17% Impact
gurufocus.com
2026-02-17 18:03:00Exploring the Latest 13F Filing and Investment Adjustments Daniel Loeb (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, pr
Danaher to Acquire Masimo in $9.9 Billion All-Cash Deal
gurufocus.com
2026-02-17 11:14:00Danaher has announced its plan to acquire Masimo (MASI) for $180 per share in an all-cash transaction. This represents a 38% premium over Masimo's previous clos
Shares of Masimo, Danaher Moving on Acquisition Buzz
schaeffersresearch.com
2026-02-17 10:32:39Medical technology stock Masimo Corp (NASDAQ:MASI) is soaring today, last seen up 34.3% to trade at $174.78, after reports that the company is nearing an agreement to be acquired by Danaher Corp (NYSE:DHR) in an all-cash deal worth roughly $10 billion.
Danaher to acquire Masimo in $9.9B all-cash deal
proactiveinvestors.com
2026-02-17 09:40:13Danaher Corporation (NYSE:DHR) announced it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI) in an all-cash transaction valued at approximately $9.9 billion, as the life sciences and diagnostics company looks to expand its patient monitoring capabilities. Under the terms of the agreement, Danaher will acquire all outstanding Masimo common shares for $180 per share in cash.
Danaher to buy Masimo for $9.9 billion
reuters.com
2026-02-17 08:04:27Danaher will acquire pulse oximeter maker Masimo for $9.9 billion, the company said on Tuesday, as the contract research firm looks to bulk up its diagnostics portfolio.
Masimo to be Acquired by Danaher for $180.00 Per Share
businesswire.com
2026-02-17 08:02:00IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) (“Danaher”) will acquire Masimo for $180.00 per share in cash, representing a total consideration of $9.9 billion (the “Transaction”). The Transaction has been unanimously approved by both Masimo's Board of Directors and Danaher's Board of Directors. Masimo will become.
Danaher To Acquire Masimo Corporation
prnewswire.com
2026-02-17 08:00:00WASHINGTON, Feb. 17, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI) a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, Danaher will acquire all of the outstanding shares of Masimo common stock for $180 per share in cash, or a total enterprise value of approximately $9.9 billion including assumed indebtedness and net of acquired cash.
First Look: WBD waiver; Ackman's Meta bet; Ford-China JV
gurufocus.com
2026-02-17 07:39:00Stock News WBD reopens rival talks under Netflix waiver: Warner Bros. Discovery (WBD) received a seven-day waiver from Netflix (NFLX) to resume talks with Param
Baron Durable Advantage Fund Q4 2025 Performance Review
seekingalpha.com
2026-02-26 02:00:00During the fourth quarter, we initiated a new position in the leading energy-focused specialty contracting company, Quanta Services. Within the existing portfolio, our biggest addition during the quarter was to MSCI, a leading provider of indexes and investment decision support tools. We also added to our position in Danaher Corporation.
Danaher Announces Quarterly Dividend
prnewswire.com
2026-02-24 16:30:00WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026 to holders of record on March 27, 2026. ABOUT DANAHER Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health.
Danaher to Present at TD Cowen Health Care Conference
prnewswire.com
2026-02-24 16:05:00WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 3, 2025 at 1:50 p.m.
Clearstead Advisors LLC Grows Stock Position in Danaher Corporation $DHR
defenseworld.net
2026-02-23 06:12:42Clearstead Advisors LLC grew its position in shares of Danaher Corporation (NYSE: DHR) by 4.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 93,939 shares of the conglomerate's stock after buying an additional 3,589 shares during the period. Clearstead Advisors LLC's
Danaher Corporation $DHR Position Boosted by Avalon Trust Co
defenseworld.net
2026-02-23 04:05:04Avalon Trust Co lifted its holdings in Danaher Corporation (NYSE: DHR) by 5.1% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 78,807 shares of the conglomerate's stock after purchasing an additional 3,847 shares during the period. Danaher comprises 1.0% of
Beverly Hills Private Wealth LLC Acquires Shares of 3,382 Danaher Corporation $DHR
defenseworld.net
2026-02-21 04:18:47Beverly Hills Private Wealth LLC bought a new position in shares of Danaher Corporation (NYSE: DHR) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,382 shares of the conglomerate's stock, valued at approximately $671,000. Other large investors have also
Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI
businesswire.com
2026-02-18 20:30:00NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Masimo Corporation (NasdaqGS: MASI) to Danaher Corporation (NYSE: DHR). Under the terms of the proposed transaction, shareholders of Masimo will receive $180.00 in cash for each share of Masimo that they own. KSF is seeking to determine whether this consideration and the process that led to it are a.
Danaher's $9.9B Masimo Deal Marks One of 2026's Largest Medtech Buyouts
247wallst.com
2026-02-18 08:50:55Danaher (NYSE: DHR) is acquiring Masimo (NASDAQ: MASI) for $9.9 billion in an all-cash deal that values the medical technology company at $180 per share.
Daniel Loeb's Strategic Moves: Flutter Entertainment PLC Exits with -3.17% Impact
gurufocus.com
2026-02-17 18:03:00Exploring the Latest 13F Filing and Investment Adjustments Daniel Loeb (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, pr
Danaher to Acquire Masimo in $9.9 Billion All-Cash Deal
gurufocus.com
2026-02-17 11:14:00Danaher has announced its plan to acquire Masimo (MASI) for $180 per share in an all-cash transaction. This represents a 38% premium over Masimo's previous clos
Shares of Masimo, Danaher Moving on Acquisition Buzz
schaeffersresearch.com
2026-02-17 10:32:39Medical technology stock Masimo Corp (NASDAQ:MASI) is soaring today, last seen up 34.3% to trade at $174.78, after reports that the company is nearing an agreement to be acquired by Danaher Corp (NYSE:DHR) in an all-cash deal worth roughly $10 billion.
Danaher to acquire Masimo in $9.9B all-cash deal
proactiveinvestors.com
2026-02-17 09:40:13Danaher Corporation (NYSE:DHR) announced it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI) in an all-cash transaction valued at approximately $9.9 billion, as the life sciences and diagnostics company looks to expand its patient monitoring capabilities. Under the terms of the agreement, Danaher will acquire all outstanding Masimo common shares for $180 per share in cash.
Danaher to buy Masimo for $9.9 billion
reuters.com
2026-02-17 08:04:27Danaher will acquire pulse oximeter maker Masimo for $9.9 billion, the company said on Tuesday, as the contract research firm looks to bulk up its diagnostics portfolio.
Masimo to be Acquired by Danaher for $180.00 Per Share
businesswire.com
2026-02-17 08:02:00IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) (“Danaher”) will acquire Masimo for $180.00 per share in cash, representing a total consideration of $9.9 billion (the “Transaction”). The Transaction has been unanimously approved by both Masimo's Board of Directors and Danaher's Board of Directors. Masimo will become.
Danaher To Acquire Masimo Corporation
prnewswire.com
2026-02-17 08:00:00WASHINGTON, Feb. 17, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI) a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, Danaher will acquire all of the outstanding shares of Masimo common stock for $180 per share in cash, or a total enterprise value of approximately $9.9 billion including assumed indebtedness and net of acquired cash.
First Look: WBD waiver; Ackman's Meta bet; Ford-China JV
gurufocus.com
2026-02-17 07:39:00Stock News WBD reopens rival talks under Netflix waiver: Warner Bros. Discovery (WBD) received a seven-day waiver from Netflix (NFLX) to resume talks with Param